InBrain Neuroelectronics announced today that it received a $4.5 million (€4 million) grant from Spain’s PERTE Chip Program.

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Aurora nuclear medicine system and ...

Zimmer Biomet reported Street-beating Q1 results and upped its revenue guidance, though it cut its EPS projections amid ...

Integra LifeSciences (Nasdaq: IART) shares took a hit today on first-quarter results that came in mixed compared to the ...

Before HeartBeam, Eno served as CEO of Preview Medical, a diagnostic equipment company. Prior to that, he held the role of ...

SS Innovations today reiterated its first-quarter guidance as it continues to report additional installations of its surgical ...

Smith+Nephew (NYSE: SNN) today announced plans for a months-long roadshow across Central Europe to promote its Cori surgical ...

CEO Jason Hollar said Cardinal Health is "engaging" with the Trump Administration "to try to mitigate impact to patient care.

Endogenex said the study "demonstrates substantial and durable reduction in insulin resistance and improvement in beta cell ...

The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

Rhythm Technologies shares are on the rise on first-quarter results that were mixed compared to the Wall Street forecast.